Iron Horse Acquisition II Corp. (IRHO) Stock Analysis

Price updated 4 days ago · SEC data refreshed 3 months ago · Not investment advice

Iron Horse Acquisition II Corp.

IRHO Financial Services SPACs📄 SEC filings ↗
Valuation N/A
▾ What's in the 27/100 risk score? (higher = riskier)
Fundamental health (43%) 20/100 → +8.6
leverage 20/100
Smart money (short interest + insider buying) (31%) 31/100 → +9.7
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (26%) 33/100 → +8.5
Total27/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). See the Financial Health section for the full balance-sheet read.

💵 Price $10.06 · 4 days ago 📄 Financials SEC EDGAR · refreshed 3 months ago

How to read IRHO (pre-profit growth)

This company is reinvesting instead of generating profit, so a standard DCF cannot price it. The useful question is whether the growth the market is paying for is achievable — and whether the company can fund itself until then.

Where to start — the sections that matter most for this stock
  1. 1 Reverse-DCF — the growth the price demands ↓
    It shows exactly how fast the business must grow to justify today's price. Compare that to what comparable companies have actually achieved.
  2. 2 Cash runway ↓
    Can it reach profitability before it has to raise money and dilute shareholders?
  3. 3 Interactive calculator ↓
    Set your own growth + margin assumptions and see what the business would be worth if you are right.
Or — what are you trying to decide?
A note on process: fear-driven decisions — including fear of missing out — tend to be the expensive ones. A stock up 10% a day for three days is excitement, not evidence. Whichever reader you are, the data below is there to be checked before anything is decided.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.
ⓘ We have only partial financials for this filer

IRHO's SEC filings give us limited machine-readable financials — common for some foreign or newly-listed filers that report under IFRS or file abbreviated statements. We can't run a full valuation on a partial dataset.

What to use instead: What we have parsed is shown below. As more complete filings arrive (or IFRS support lands), the valuation will populate.

ⓘ Why does IRHO trade at $10.06?

Iron Horse Acquisition II Corp. has 5.0 million shares outstanding. At $10.06 per share, the market values all outstanding IRHO equity at $50 million. That's market capitalization, not enterprise value — enterprise value also accounts for debt and cash (IRHO carries little or no debt, so the two are close here). The share price by itself tells you almost nothing — a company can pick any share price by splitting or issuing more shares. What matters is the total value (Market Cap?Market Cap — The total dollar value the market is assigning to the entire company.
Why it matters: This is the number that actually matters when comparing companies. Two companies with the same business but different share counts have the same market cap.
Reference: Mega cap >$200B · Large $10–200B · Mid $2–10B · Small $300M–2B · Micro <$300M
Full explanation →
) compared to what the business actually produces. This page values IRHO in Per Share?Per Share — A company-level figure divided by total shares — what one share represents.
Why it matters: Per-share metrics are the only way to fairly compare two companies with different share counts.
Full explanation →
economics — what each share represents of the underlying business. Play with the share-price calculator on the homepage →

Loading insider & short-seller data…

Riskier than 68% of the stocks we cover

A model trained on every US filing since 2012 — including the 823 companies that went bankrupt or stopped trading under a dollar — ranks each covered stock by its chance of failing in the next year. This is a position among peers, not a prediction about this company alone. Below is what happened to stocks that sat in the same position in past years.

Below average · rank 68 of 100 (band: next 25% (50-75))
Of the stocks in this band in past years, 0.2% went bankrupt within 12 months — 0.3× the average across all covered stocks (0.59%) and 1.4× the Finance average (0.13%). Within Finance it ranks 83 of 100. 0.5% lost 80% or more of their value within a year. 2.1% fell 50% or more within six months.
▾ Every band, and what happened to the stocks in it
Rank band went bankrupt within 12 monthsfell 80% or more (or failed) within 12 monthsfell 50% or more (or failed) within 6 months
All covered stocks (average) 0.59% 4.21% 8.51%
Finance (sector average) 0.13% 1.25% 3.09%
riskiest 1% 16.4% of 1,749 33.0% of 1,998 45.5% of 2,239
next 2% (97-99) 5.9% of 3,360 24.9% of 3,985 38.2% of 4,461
next 2% (95-97) 3.4% of 3,409 21.2% of 3,984 33.8% of 4,462
next 5% (90-95) 1.6% of 8,443 15.1% of 9,965 27.3% of 11,155
next 15% (75-90) 0.8% of 25,328 8.5% of 29,884 17.8% of 33,459
next 25% (50-75) ← this stock 0.2% of 36,310 2.7% of 49,810 6.2% of 55,771
safest half <0.1% of 92,256 0.5% of 99,617 2.1% of 111,538

Counts are stock-quarters 2012–2025, scored each year by a model that had not seen that year. The rank is recomputed from each company's latest filing (this one: 2026-04-03); table generated 2026-09-17. Calibrated one-year odds for this stock alone: bankruptcy 0.2%, 80%+ fall 0.5%, 50%+ fall in six months 1.8% — treat these as rougher than the band counts; the model overstates the middle of the range.

What this is not. It is not a trade. We tested shorting these names and buying puts on them at real option prices (2010–2025): every version lost money, because the market already prices the distress and the survivors squeeze. A high rank is a reason to read the filings and to size a position for the chance of a total loss — not a reason to bet against the company. A low rank says the balance sheet and the market are calm; it says nothing about whether the price is sensible.

Checking filings for failure warnings…

How does IRHO stack up against its closest peers?

We take the 8 same-industry companies most similar to IRHO (similar size) and check what investors are paying for each dollar of their revenue (or profits). If IRHO is much more expensive on the same yardstick, that's a red flag — unless you have a specific reason it deserves a premium.

▾ What's "EV / Sales" in plain English?

EV (Enterprise Value) = market cap + total debt − cash. It's "what you'd pay to buy the entire company outright" — you pay the market cap to shareholders and take over their debt, but you keep their cash. EV is fairer than market cap alone because it includes the debt the new owner inherits.

EV / Sales = EV ÷ annual revenue. So "2.5×" means investors pay $2.50 of enterprise value per $1 of yearly sales. Higher = market is paying more per dollar of sales (usually because they expect future growth or fat margins).

p25 / median / p75 are the 25th, 50th (middle), and 75th percentile of the peers' multiples. Half the peers fall between p25 and p75. The median (p50) is the typical peer — that's the benchmark we compare to.

What peers trade at (p25 / median / p75)

Bold middle number = median peer. Half the peers trade above it, half below. Computed over 8 same-industry peers; implausible multiples excluded.

Peer-implied value check
Revenue/share data missing for IRHO — can't compute a peer-implied price. The multiples table above still works as context.

⚠️ Important caveat: peer multiples only work if the peers are genuinely comparable. Always check the peer list below — if the auto-picker grabbed micro-caps or unrelated businesses, the comparison is noise. A medical-device giant priced against tiny biotech startups won't produce a useful signal.

▾ View peer list (8)
Ticker Company Industry Mcap EV/Sales EV/GPEV/EBIT FCF Yield
YHNA YHN Acquisition I Ltd SPACs $47M
UYSC UY Scuti Acquisition Corp. SPACs $56M
SSEA STARRY SEA ACQUISITION CORP SPACs $78M
WSTN Westin Acquisition Corp SPACs $82M
YCY AA Mission Acquisition Corp. II SPACs $121M
VECA Vernal Capital Acquisition Corp. SPACs $131M
XFLH XFLH Capital Corp SPACs $138M
TRAD APEX Tech Acquisition Inc. SPACs $142M

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
Not available for this filer

The Z-score needs working capital, retained earnings, EBIT, sales and total assets from the latest balance sheet, and at least one of those isn't reported in machine-readable form here — common for foreign private issuers. We leave it blank rather than compute a distress verdict from an estimated input. It doesn't affect the reported figures in the financial tables below.

Piotroski F-Score?Piotroski F-Score — A 9-point quality checklist scoring profitability, leverage, and operating efficiency.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
Not available for this filer

The F-score compares two consecutive years of income, cash-flow and balance-sheet data. This filer has only 1 usable year, so there is no prior period to compare against. We show nothing rather than score a partial year against itself. The reported figures in the financial tables below are unaffected.

Cash Runway
0 mo
CRITICAL — under 6 months of cash

Plain English: the company holds about $0M in cash and is burning roughly $0M/year in operations. At that pace, the cash lasts 0 mo before it must raise capital (diluting shareholders), take on debt, or cut spending.

Assumes constant burn and ignores financing/asset sales. For pre-profit biotech and growth companies, this matters more than a DCF — a great drug pipeline is worthless if they run out of money before approval.

Price$10.06
Model IVNot applicable — DCF couldn't price this stock. The other valuation lenses on this page (reverse-DCF, peers, sector lens — whichever apply to this filer) carry the read instead.

Analysis narrative not yet available for this stock.

⚠️ FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.

As of 3 months ago

Anatomy of a share

What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

IRHO Iron Horse Acquisition II Corp. stock anatomy showing per-share revenue, operating expenses, free cash flow, and debt
What's free cash flow / what do these mean?

Revenue per share — how much the business earns from customers, divided by the number of shares outstanding. Top of the income statement.

Earnings per share — profit left after operating costs, interest, and taxes, per share. Two versions appear on this page and are not interchangeable: GAAP diluted EPS uses the company's weighted-average diluted share count during the reporting period (this is the "earnings" in "price-to-earnings"); net income per current share divides annual net income by today's share count. They differ whenever the share count has changed.

Owner-earnings free cash flow per share — the cash the business produces for shareholders. Savng's owner-earnings FCF subtracts capital expenditures and stock-based compensation from operating cash flow (SBC is a real dilution cost even though it's non-cash). This is deliberately more conservative than "standard" FCF, which subtracts only capital expenditures — so our figure is lower than the headline FCF you'll see elsewhere. FCF funds dividends, buybacks, debt repayment, and acquisitions; a company can report positive earnings yet negative FCF.

Debt per share — total interest-bearing borrowings divided by shares. High debt-per-share next to thin FCF-per-share is a fragility signal.

Management & Leadership

Information not yet available. Executive data not available from current data sources.

What They Make

Company description not yet available.

Segment revenue breakdown not available from current data sources.
Market Cap: 50.3MBeta: 0.55

Why Is It Priced Like This?

No discounted-cash-flow value for this filer This company's reported free cash flow is negative, so a discounted-cash-flow valuation has no positive cash stream to discount. That is a fact about the business, not missing data — the reported figures below are complete.

What we use instead: earnings (P/E, EV/EBIT), book value (P/B) — computed from the figures this company does report, shown in the sections below. Those numbers are unaffected by the missing cash-flow data.
Pricing analysis not yet available for this stock.

Business Model & Valuation

Business model analysis not yet available for this stock.

Growth / Revenue DCF

Negative free cash flow: revenue/margin growth model used - standard FCF DCF is unreliable for companies still scaling.

Show advanced inputs
Revenue Growth15.0%

What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project net interest income and fee-income lines independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

Maturity & Competitive Position

Competitive analysis not yet available for this stock.

Geography & Markets

Geographic revenue mix not available from current data sources.

Market Signals

These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

Model neutral, tape neutral - aligned.
RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
Reference: 30–70 normal · >70 overbought · <30 oversold
Full explanation →
(14)
68.1NeutralMomentum is balanced — neither overbought nor oversold.
MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
Reference: Line above signal = bullish momentum · below = bearish
Full explanation →
BullishLine above signalThe fast trend is above the slow trend — short-term momentum is currently upward.
50-Day Average$9.94Price above (+1.2%)Price above its 50-day average = near-term uptrend.

Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

Data Quality & Risk Flags (4 notes — click to expand/collapse)

Guardrail Notes (4)
  • FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.
  • INVARIANT: weighted IV is non-positive. Model may not be appropriate.
  • Model implies no positive equity value under these assumptions. Valuation is speculative/low-confidence.
  • Illiquidity discount 15% applied (small/micro-cap — harder to exit, demand a margin).

Financial Statements (5-year tables — click to expand)

From Iron Horse Acquisition II Corp.'s SEC filings (EDGAR).

Income (5yr)

YearRevenueNet IncomeEPS
2025-204,391$-0.04

Cash Flow (5yr)

Capital expenditure isn't tagged in this filer's machine-readable data (the CapEx column shows "—"). The free-cash-flow column is therefore operating cash flow less stock-based compensation only — an upper bound on true owner earnings, not the real figure. Companies that report capex under a custom label (some large IFRS filers do) look better here than they are.

YearOperating CFCapEx− SBC & adj.Free Cash Flow
2025 -142,761 -142,761

How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). This is the same owner-earnings FCF definition the valuation model uses, though the DCF's starting value is a projected from revenue × terminal margin, not this single year.

Balance Sheet

Total Assets364,681
Total Liabilities538,347 (derived)
Equity-173,666
PG
Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
🔔 Follow $IRHO — free insider alerts
One email when an insider buys $IRHO on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.